Last checked at 9 Aug 2019 14:40
9 August 2019
Assura plc
Additional Listing
Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that, 323,781 New Ordinary Shares (the "New Shares") have been issued to the Assura plc Employee Benefit Trust in order to satisfy the awards pursuant to the 2016 Performance Share Plan.
Application has therefore been made for the admission of the New Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 12 August 2019.
Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 2,406,068,056 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 2,406,068,056.
For more information, please contact:
Assura plc | Tel: 01925 420660 |
Orla Ball, Company Secretary | |
David Purcell, Head of Financial Reporting | |
Finsbury | Tel: 0207 251 3801 |
Gordon Simpson |
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.
LEI : 21380026T19N2Y52XF72